Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07547072Not ApplicableNot Yet Recruiting

Choroidal Response to the Modified Defocus Incorporated Multiple Segments Spectacle Lenses

Role: collaborator

NCT05888792Not ApplicableActive Not Recruiting

Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes

Role: collaborator

NCT05888805Not ApplicableActive Not Recruiting

Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes - Auxiliary Group

Role: collaborator

NCT05886348Not ApplicableActive Not Recruiting

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

Role: lead

NCT06781931Not ApplicableRecruiting

DG1 Spectacle Lens for Myopia Progression Control in Children

Role: lead

All 5 trials loaded